about
Nucleotide excision repair gene variants and association with survival in osteosarcoma patients treated with neoadjuvant chemotherapy.Candidate germline polymorphisms of genes belonging to the pathways of four drugs used in osteosarcoma standard chemotherapy associated with risk, survival and toxicity in non-metastatic high-grade osteosarcoma.Pharmacology of epidermal growth factor inhibitors.Polymorphic thymidylate synthase gene impacts on overall survival of patients with epithelial ovarian cancer after platinum-based chemotherapyA New Genetic Risk Score to Predict the Outcome of Locally Advanced or Metastatic Breast Cancer Patients Treated With First-Line Exemestane: Results From a Prospective StudyPrognostic Role of a New Index (RAPID Index) in Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib: Training and Validation CohortA validated prognostic classifier for V600EBRAF-mutated metastatic colorectal cancer: the 'BRAF BeCool' studyClass 1, 2, and 3 BRAF-Mutated Metastatic Colorectal Cancer: A Detailed Clinical, Pathologic, and Molecular CharacterizationCK7 and consensus molecular subtypes as major prognosticators in V600EBRAF mutated metastatic colorectal cancer
P50
Q33985880-4F840164-13D2-4593-A65F-C3136BC540E2Q37641721-6104B8C2-3C66-4A73-BA94-24717CB9C2EDQ53580315-E1703E8C-2947-45BD-BC57-95A287809602Q85423146-22A73001-E3AB-4BE8-BA9F-23F92DE4803FQ90744602-423F509A-75D4-4CC4-A4B6-D54437D22978Q91454002-46A40938-25A6-4718-A8D1-979665A848FEQ92079267-F0718C60-B017-490F-A9FE-198D460C71B9Q92985775-BE95FDC6-8781-41B6-8302-96A18A635040Q93046337-585991D7-8410-4604-92C3-21F1E5CF70ED
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
P Biason
@ast
P Biason
@en
P Biason
@es
P Biason
@nl
type
label
P Biason
@ast
P Biason
@en
P Biason
@es
P Biason
@nl
prefLabel
P Biason
@ast
P Biason
@en
P Biason
@es
P Biason
@nl
P108
P106
P31
P496
0000-0002-2298-101X